IN8bio Statistics

Total Valuation

IN8bio has a market cap or net worth of $14.43 million. The enterprise value is $8.60 million.

Market Cap	14.43M
Enterprise Value	8.60M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

IN8bio has 81.26 million shares outstanding. The number of shares has increased by 79.30% in one year.

Current Share Class	81.26M
Shares Outstanding	81.26M
Shares Change (YoY)	+79.30%
Shares Change (QoQ)	+62.96%
Owned by Insiders (%)	7.49%
Owned by Institutions (%)	13.77%
Float	53.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.95
P/TBV Ratio	1.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.35.

Current Ratio	4.08
Quick Ratio	3.61
Debt / Equity	0.35
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -154.44% and return on invested capital (ROIC) is -74.99%.

Return on Equity (ROE)	-154.44%
Return on Assets (ROA)	-67.70%
Return on Invested Capital (ROIC)	-74.99%
Return on Capital Employed (ROCE)	-165.72%
Revenue Per Employee	n/a
Profits Per Employee	-$1.69M
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.92% in the last 52 weeks. The beta is 0.24, so IN8bio's price volatility has been lower than the market average.

Beta (5Y)	0.24
52-Week Price Change	-82.92%
50-Day Moving Average	0.21
200-Day Moving Average	0.35
Relative Strength Index (RSI)	46.61
Average Volume (20 Days)	726,637

Short Selling Information

The latest short interest is 478,257, so 0.59% of the outstanding shares have been sold short.

Short Interest	478,257
Short Previous Month	1.01M
Short % of Shares Out	0.59%
Short % of Float	0.90%
Short Ratio (days to cover)	0.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.60M
Pretax Income	-31.96M
Net Income	-30.44M
EBITDA	-27.76M
EBIT	-29.60M
Earnings Per Share (EPS)	-$0.57

Full Income Statement

Balance Sheet

The company has $11.12 million in cash and $5.03 million in debt, giving a net cash position of $6.09 million or $0.07 per share.

Cash & Cash Equivalents	11.12M
Total Debt	5.03M
Net Cash	6.09M
Net Cash Per Share	$0.07
Equity (Book Value)	14.48M
Book Value Per Share	0.20
Working Capital	9.50M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$24.15 million and capital expenditures -$187,000, giving a free cash flow of -$24.34 million.

Operating Cash Flow	-24.15M
Capital Expenditures	-187,000
Free Cash Flow	-24.34M
FCF Per Share	-$0.30

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IN8bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-79.30%
Shareholder Yield	-79.30%
Earnings Yield	-207.17%
FCF Yield	-165.65%

Analyst Forecast

The average price target for IN8bio is $3.60, which is 1,927.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.60
Price Target Difference	1,927.03%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1